MD Anderson president elected to top cancer research academy
Ron DePinho, M.D., president of MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer Research (AACR) Academy. He joins 10 other cancer leaders as new inductees in the prestigious academy, which recognizes those who've made significant contributions to cancer research.
All fellows are nominated and elected through a rigorous peer-review process conducted by existing AACR members and...
The mystery of what turns a protein to the dark side
Scottish author Robert Louis Stevenson tapped into primal fears when he penned “Dr. Jekyll and Mr. Hyde,” a 19th-century novel about a sinister...
In the press, among peers, Melanoma Moon Shot communicates tanning risk
MD Anderson’s Moon Shots Program continues to keep the issue of indoor tanning — and its impact on teenagers — in the public eye.
The...
Eight signs associated with impending cancer death are identified
Researchers at MD Anderson have identified eight highly specific physical and cognitive signs associated with imminent death in cancer patients. The findings, published in the journal Cancer, could offer clinicians the ability to better communicate with patients and families. They may also guide both the medical team and caregivers on complex decision making, such as discontinuation of tests and therapy, plans for hospital discharge and...
Understanding the architecture of disease
When skyscrapers go up, contractors rely on an infrastructure of steel beams and braces. Some cancers grow the same way, using a biological...
Collaboration should lead to better mining of clinical trial data
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and...
Less surgery and better survival rates for patients with metastatic colorectal cancer
Thanks to the modern era of new chemotherapeutic and biologic agents available for managing their disease, patients with metastatic colorectal...
Working together to 'move the needle'
MD Anderson continues to rethink how industry and academia can collaborate in deeper and broader ways to develop new drugs and bring improved...
Joining with AstraZeneca to take on ovarian and gynecologic cancers
MD Anderson and AstraZeneca recently announced a multi-year strategic research collaboration to conduct multiple, parallel clinical and clinically...
MD Anderson receives top Chinese science and technology award
MD Anderson was presented the People’s Republic of China International Science and Technology Cooperation Award last month at a ceremony at...
Shorter radiation course at higher doses may be beneficial
A shorter course of radiation therapy at higher doses per fraction than the standard regimen could reduce side effects and improve quality...
World Cancer Day and MD Anderson's daily mission
Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed to...